Private equity and venture capital are fuelling breakthroughs in life science, but when billions are on the line, disputes can derail the most promising deals. This panel dives into the high-stakes world of PE and VC investments, exploring where issues arise and how they are resolved. From valuation battles to governance clashes and exit strategies, hear insider perspectives on managing risk and keeping deals on track.